Wakamoto Pharmaceutical Co.,Ltd. (TYO:4512)

Revenue by Product

Financials in millions JPY. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005
Pharmaceutical	3.47B
Pharmaceutical Growth	2.35%
Healthcare	2.35B
Healthcare Growth	-4.39%
Global	1.79B
Global Growth	4.10%
Real Estate Rental	182.59M
Real Estate Rental Growth	4.83%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Year Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013	Mar 31, 2012	Mar 31, 2011	Mar 31, 2010	Mar 31, 2009	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005
Japan	7.79B
Japan Growth	0.66%